ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

A Four-Gene Panel for the Prediction of Prognosis and Immune Cell Enrichment in Gliomas

Li, Zhiyong; Jin, Yinghui; Zhang, Peidong; Zhang, Xi-an; Yi, Guozhong; Zheng, Haojie; Yuan, Xi; Wang, Xiaoyan; Xu, Haiyan; Qiu, Xiaoyu; Chen, Chao; Que, Tianshi*; Huang, Guanglong*南方医科大学
MOLECULAR BIOTECHNOLOGY2023-8-29DOI: 10.1007/s12033-023-00820-0
9阅读
引用收藏
分享

摘要

BackgroundsGliomas is a deadly disease without effective therapy. Although immunotherapy has provided novel choices for glioma treatment, the curative efficacy is unsatisfactory due to the complex immune micro-environment and the heterogeneity of the disease. Therefore, it is urgent to identify effective biomarkers and therapeutic targets.MethodsOverall survival, gene ontology (GO), Kyoto Encyclopedia of Genes, and Genomes (KEGG) enrichment analysis, Gene Set Enrichment Analysis (GSEA) and immune infiltration were analyzed by bioinformatics software with The Cancer Genome Atlas (TCGA) database.ResultsBased on the TCGA database and protein-protein interaction (PPI) analysis revealed a four-gene panels [DNA topoisomerase II alpha (TOP2A); ribonucleotide reductase regulatory subunit M2 (RRM2); kinesin family member 20 A (KIF20A) and DLG associated protein 5 (DLGAP5)], which correlated with poor prognosis, including overall survival (OS), disease specific survival (DSS) and progress free interval (PFI), mitosis, cell cycle, Th2 cells and macrophages enrichment. The four-gene panels correlates with the biomarkers of Th2 cells, macrophages tumor-associated macrophages (TAMs) and the immune checkpoint molecules in gliomas.ConclusionThe four-gene panels represented a novel prognostic indicator and potential therapeutic target for the treatment of glioma. In addition, the four-gene panels might contribute to enhance the efficacy of immunotherapy in glioma.

学科与关键词

关键词
GliomaImmunotherapyImmune infiltrationPrognosisTOP2A
相关
加载中…
  • Comprehensive Analysis of Expression and Prognostic Value of MS4As in Glioma
    Zeng, Yingying; Tan, Peixin; Ren, Chen; Gao, Lianxuan; Chen, Yulei; Hu, Shushu; Tang, Nan; Chen, Chen; Du, Shasha*Frontiers in Genetics, 2022, 13: 795844.被引 6
  • Identification of PYGL as a key prognostic gene of glioma by integrated bioinformatics analysis
    Zhu, Yongjie; Liu, Zhendong; Lv, Dongbo; Cheng, Xingbo; Wang, Jialin; Liu, Binfeng; Han, Zhibin; Wangs, Yanbiao; Liu, Runze; Gao, Yanzheng*Future Oncology, 2022, 18(5): 579-596.被引 4
  • Prognostic Features of the Tumor Immune Microenvironment in Glioma and Their Clinical Applications: Analysis of Multiple Cohorts
    Zhang, Chunlong; Zhang, Yuxi; Tan, Guiyuan; Mi, Wanqi; Zhong, Xiaoling; Zhang, Yu; Zhao, Ziyan; Li, Feng*; Xu, Yanjun*; Zhang, Yunpeng*Frontiers in Immunology, 2022, 13: 853074.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
MOLECULAR BIOTECHNOLOGY
发表日期
2023-08-29
DOI
10.1007/s12033-023-00820-0
语言
ENGLISH
成果收录
SCIE

作者

  • L

    Li, Zhiyong (第一作者)

    southern med univ

  • J

    Jin, Yinghui

    southern med univ

查看全部 13 位作者收起作者
  • Z

    Zhang, Peidong

    southern med univ

  • Z

    Zhang, Xi-an

    southern med univ

  • Y

    Yi, Guozhong

    southern med univ

  • Z

    Zheng, Haojie

    southern med univ

  • Y

    Yuan, Xi

    southern med univ

  • W

    Wang, Xiaoyan

    southern med univ

  • X

    Xu, Haiyan

    southern med univ

  • Q

    Qiu, Xiaoyu

    southern med univ

  • C

    Chen, Chao

    southern med univ

  • Q

    Que, Tianshi (通讯)

    southern med univ

  • H

    Huang, Guanglong (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417